HighTower Advisors’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

HighTower Advisors’s Portfolio SKBI Stock Details SKBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-22,845	Closed	-$22K	–	2198
2015 Q3	$22K	Buy	22,845 +3,000	+15%	+$4.81K	﹤0.01%	1820
2015 Q2	$53K	Buy	+19,845	New	+$67.9K	﹤0.01%	1450
2014 Q3	–	Sell	-11,545	Closed	-$85K	–	1716
2014 Q2	$85K	Buy	+11,545	New	+$68.9K	﹤0.01%	1481

Other funds holding SKBI

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

HighTower Advisors's SKBI Position: Q4 2015 in Review

HighTower Advisors sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q4 2015, closing a stake of 22,845 shares — an estimated $22K sold.

HighTower Advisors first reported a position in SKBI in Q2 2014 and held it in 3 quarters. The position peaked at $85K in Q2 2014. 1 fund tracked by Wall St. Rank holds SKBI as of Q4 2015.

HighTower Advisors reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q4 2015 after selling out during the quarter.
HighTower Advisors sold 22,845 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q4 2015, an estimated $22K.
HighTower Advisors first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q2 2014 and held it in 3 quarters.
HighTower Advisors's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $85K in Q2 2014.
1 fund tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q4 2015.

Based on HighTower Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.